Travere Therapeutics Inc (NASDAQ: TVTX) on Friday, soared 3.97% from the previous trading day, before settling in for the closing price of $17.63. Within the past 52 weeks, TVTX’s price has moved between $5.12 and $25.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 13.83% annually for the last half of the decade. The company achieved an average annual earnings per share of 67.89%. With a float of $87.44 million, this company’s outstanding shares have now reached $87.45 million.
In an organization with 385 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 92.24%, operating margin of -138.0%, and the pretax margin is -137.45%.
Travere Therapeutics Inc (TVTX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Travere Therapeutics Inc is 1.50%, while institutional ownership is 109.06%. The most recent insider transaction that took place on Apr 11 ’25, was worth 631. In this transaction CHIEF FINANCIAL OFFICER of this company sold 48 shares at a rate of $13.14, taking the stock ownership to the 89,990 shares. Before that another transaction happened on Apr 11 ’25, when Company’s Officer proposed sale 48 for $13.14, making the entire transaction worth $631.
Travere Therapeutics Inc (TVTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.89% per share during the next fiscal year.
Travere Therapeutics Inc (NASDAQ: TVTX) Trading Performance Indicators
Travere Therapeutics Inc (TVTX) is currently performing well based on its current performance indicators. A quick ratio of 2.04 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.10, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach 1.17 in one year’s time.
Technical Analysis of Travere Therapeutics Inc (TVTX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.37 million. That was inferior than the volume of 1.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 92.31%. Additionally, its Average True Range was 1.20.
During the past 100 days, Travere Therapeutics Inc’s (TVTX) raw stochastic average was set at 43.78%, which indicates a significant decrease from 97.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.09% in the past 14 days, which was higher than the 61.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.77, while its 200-day Moving Average is $16.24. However, in the short run, Travere Therapeutics Inc’s stock first resistance to watch stands at $18.76. Second resistance stands at $19.18. The third major resistance level sits at $19.92. If the price goes on to break the first support level at $17.60, it is likely to go to the next support level at $16.86. The third support level lies at $16.44 if the price breaches the second support level.
Travere Therapeutics Inc (NASDAQ: TVTX) Key Stats
Market capitalization of the company is 1.63 billion based on 88,772K outstanding shares. Right now, sales total 233,180 K and income totals -321,550 K. The company made 74,790 K in profit during its latest quarter, and -60,260 K in sales during its previous quarter.
